0001213900-20-043366.txt : 20201218
0001213900-20-043366.hdr.sgml : 20201218
20201218062037
ACCESSION NUMBER: 0001213900-20-043366
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201216
FILED AS OF DATE: 20201218
DATE AS OF CHANGE: 20201218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HULL ANDREW
CENTRAL INDEX KEY: 0001818252
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39685
FILM NUMBER: 201397954
MAIL ADDRESS:
STREET 1: C/O INMED PHARMACEUTICALS INC.
STREET 2: SUITE 310 - 815 HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2020-12-16
0
0001728328
InMed Pharmaceuticals Inc.
INM
0001818252
HULL ANDREW
C/O INMED PHARMACEUTICALS INC.
310-815 WEST HASTINGS ST.
VANCOUVER
A1
V6C1B4
BRITISH COLUMBIA, CANADA
1
0
0
0
Employee Stock Option (Right to Buy)
3.02
2020-12-16
4
A
0
7000
0.00
A
2025-12-15
Common shares
7000
7000
D
The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00.
The options were granted on 12/16/2020 and will vest 100% on the one year anniversary of the grant date (Dec 16, 2021) or immediately prior to the next AGM, whichever is sooner.
/s/ Bruce Colwill, attorney-in-fact for Mr. Andrew Hull
2020-12-17